Pathogenesis of chagas' disease: Parasite persistence and autoimmunity

Clinical Microbiology Reviews

Volumn 24, Issue 3, 2011, Pages 592-630

  Teixeira, Antonio R L ^a   Hecht, Mariana M ^a   Guimaro, Maria C ^a   Sousa, Alessandro O ^a   Nitz, Nadjar ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS DNA; CYTOKINE; KINETOPLAST DNA; NIFURTIMOX;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CARDIOMYOPATHY; CELL ULTRASTRUCTURE; CELLULAR IMMUNITY; CHAGAS DISEASE; CHICKEN; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; GASTROINTESTINAL DISEASE; GENE MUTATION; GENETIC ORGANIZATION; GENETIC RECOMBINATION; GENOME; GERM CELL; HERITABILITY; HOST PARASITE INTERACTION; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; INNATE IMMUNITY; MUTATIONAL ANALYSIS; NEUROENDOCRINE DISEASE; NONHUMAN; PATHOGENESIS; PERSISTENT INFECTION; POLYMERASE CHAIN REACTION; RABBIT; REDUVIIDAE; SOMATIC CELL; SYSTEMIC DISEASE; TRYPANOSOMA CRUZI; VERTEBRATE; VERTICAL TRANSMISSION;

ANIMALS; AUTOIMMUNITY; CHAGAS DISEASE; CHICKENS; DISEASE MODELS, ANIMAL; HUMANS; TRYPANOSOMA CRUZI;

EID: 79960111031     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00063-10     Document Type: Article

References (469)

1. Abel, L. C., et al. 2005. T cell epitope characterization in tandemly repetitive Trypanosoma cruzi B13 protein. Microbes Infect. 7:1184-1195.
2. Abrahamsohn, I. A., and W. D. Silva. 1977. Antibody dependent cellmediated cytotoxicity against Trypanosoma cruzi. Parasitology 75:317-323.
3. Ackermann, A. A., S. J. Carmona, and F. Agüero. 2009. TcSNP: a database of genetic variation in Trypanosoma cruzi. Nucleic Acids Res. 37:D544-D549.
4. Acosta, A. M., and C. A. Santos-Buch. 1985. Autoimmune myocarditis induced by Trypanosoma cruzi. Circulation 71:1255-1261.
5. Acosta-Serrano, A., I. C. Almeida, L. H. Freitas, N. Yoshida, and S. Schenkman. 2001. The mucin-like glycoprotein super-family of Trypanosoma cruzi: structure and biological roles. Mol. Biochem. Parasitol. 114: 143-150.
6. Adad, S. J., et al. 2001. Neuron count reevaluation in the myenteric plexus of chagasic megacolon after morphometric neuron analysis. Virchows Arch. 438:254-258.
7. Adad, S. J., D. C. Andrade, E. R. Lopes, and E. Chapadeiro. 1991. Pathological anatomy of chagasic megaesophagus. Rev. Inst. Med. Trop. Sao Paulo 33:443-450.
8. Afzali, B., G. Lombardi, R. I. Lechler, and G. M. Lord. 2007. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin. Exp. Immunol. 148:32-46.
9. Agüero, F., W. Zheng, D. B. Weatherly, P. Mendes, and J. C. Kissinger. 2006. TcruziDB: an integrated, post-genomics community resource for Trypanosoma cruzi. Nucleic Acids Res. 34:D428-D431.
10. Alarcón de Noya, B., et al. 2010. Large urban outbreak of orally acquired acute Chagas disease at a school in Caracas, Venezuela. J. Infect. Dis. 201:1308-1315.
11. Albareda, M. C., et al. 2009. Chronic human infection with Trypanosoma cruzi drives CD4 T cells to immune senescence. J. Immunol. 183:4103-4108.
12. Almeida, I. C., R. Gazzinelli, M. A. Ferguson, and L. R. Travassos. 1999. Trypanosoma cruzi mucins: potential functions of a complex structure. Mem. Inst. Oswaldo Cruz 94(Suppl. 1):173-176.
13. Alves, M. J., and W. Colli. 2008. Role of the gp85/trans-sialidase superfamily of glycoproteins in the interaction of Trypanosoma cruzi with host structures. Subcell. Biochem. 47:58-66.
14. Andersson, B., et al. 1998. Complete sequence of a 93.4-kb contig from chromosome 3 of Trypanosoma cruzi containing a strand-switch region. Genome Res. 8:809-816.
15. Andrade, L. O., and N. W. Andrews. 2004. Lysosomal fusion is essential for the retention of Trypanosoma cruzi inside host cells. J. Exp. Med. 200: 1135-1143.
16. Andrade, L. O., and N. W. Andrews. 2005. The Trypanosoma cruzi-host-cell interplay: location, invasion, retention. Nat. Rev. Microbiol. 3:819-823.
17. Andrade, S. G., and Z. A. Andrade. 1966. Chagas disease and neuronal alterations at the Auerbach's plexus. Rev. Inst. Med. Trop. Sao Paulo 8:219-224.
18. Andrade, Z. A., and S. G. Andrade. 1955. Pathogenesis of Chagas' chronic myocarditis; importance of ischemic lesions. Arq. Bras. Med. 45:279-288.
19. Andrews, N. W. 2002. Lysosomes and the plasma membrane: trypanosomes reveal a secret relationship. J. Cell Biol. 158:389-394.
20. Ansari, N. A., S. Saluja, and P. Salotra. 2006. Elevated levels of interferongamma, interleukin-10, and interleukin-6 during active disease in Indian kala azar. Clin. Immunol. 119:339-345.
21. Ansari, N. A., V. Ramesh, and P. Salotra. 2006. Interferon (IFN)-gamma, tumor necrosis factor-alpha, interleukin-6, and IFN-gamma receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis. J. Infect. Dis. 194:958-965.
22. Antúnez, M. I., and R. L. Cardoni. 2001. Early IFN-gamma production is related to the presence of interleukin (IL)-18 and the absence of IL-13 in experimental Trypanosoma cruzi infections. Immunol. Lett. 79:189-196.
23. Aras, R., J. A. da Matta, G. Mota, I. Gomes, and A. Melo. 2003. Cerebral infarction in autopsies of chagasic patients with heart failure. Arq. Bras. Cardiol. 81:414-416.
24. Araújo, A., A. M. Jansen, K. Reinhard, and L. F. Ferreira. 2009. Paleoparasitology of Chagas disease-a review. Mem. Inst. Oswaldo Cruz 104: 9-16.
25. Araújo-Jorge, T. C., et al. 2008. Pivotal role for TGF-beta in infectious heart disease: the case of Trypanosoma cruzi infection and consequent Chagasic myocardiopathy. Cytokine Growth Factor Rev. 19:405-413.
26. Araújo-Jorge, T. C., et al. 2002. Implication of transforming growth factorbeta1 in Chagas disease myocardiopathy. J. Infect. Dis. 186:1823-1828.
27. Arner, E., et al. 2007. Database of Trypanosoma cruzi repeated genes: 20,000 additional gene variants. BMC Genomics 8:391-405.
28. Arsenijevic, D., L. Girardier, J. Seydoux, H. R. Chang, and A. G. Dulloo. 1997. Altered energy balance and cytokine gene expression in a murine model of chronic infection with Toxoplasma gondii. Am. J. Physiol. 272: E908-E917.
29. Atwood, J. A., III, et al. 2005. The Trypanosoma cruzi proteome. Science 309:473-476.
30. Aufderheide, A. C., et al. 2004. A 9,000-year record of Chagas' disease. Proc. Natl. Acad. Sci. U. S. A. 101:2034-2039.
31. Aviles, H., et al. 2008. Kinetics of systemic cytokine and brain chemokine gene expression in murine toxoplasma infection. J. Parasitol. 94:1282-1288.
32. Baldauf, S. L., A. J. Roger, I. Wenk-Siefert, and W. F. Doolittle. 2000. A kingdom-level phylogeny of eukaryotes based on combined protein data. Science 290:972-977.
33. Barr, S. C. 2009. Canine Chagas' disease (American trypanosomiasis) in North America. Vet. Clin. North Am. Small Anim. Pract. 39:1055-1064.
34. Barrias, E. S., J. M. Dutra, W. De Souza, and T. M. Carvalho. 2007. Participation of macrophage membrane rafts in Trypanosoma cruzi invasion process. Biochem. Biophys. Res. Commun. 363:828-834.
35. Benvenuti, L. A., et al. 2008. Chronic American trypanosomiasis: parasite persistence in endomyocardial biopsies is associated with high-grade myocarditis. Ann. Trop. Med. Parasitol. 102:481-487.
36. Bilate, A. M., and E. Cunha-Neto. 2008. Chagas disease cardiomyopathy: current concepts of an old disease. Rev. Inst. Med. Trop. Sao Paulo 50:67-74.
37. Bittencourt, A. L., G. O. Vieira, H. C. Tavares, E. Mota, and J. Maguire. 1984. Esophageal involvement in congenital Chagas' disease. Report of a case with megaesophagus. Am. J. Trop. Med. Hyg. 33:30-33.
38. Bixby, L. M., and R. L. Tarleton. 2008. Stable CD8+ T cell memory during persistent Trypanosoma cruzi infection. J. Immunol. 181:2644-2650.
39. Bluestone, J. A., C. R. Mackay, J. J. O'Shea, and B. Stockinger. 2009. The functional plasticity of T cell subsets. Nat. Rev. Immunol. 9:811-816.
40. Bonney, K. M., J. M. Taylor, M. D. Daniels, C. L. Epting, and D. M. Engman. 2011. Heat-killed Trypanosoma cruzi induces acute cardiac damage and polyantigenic autoimmunity. PLoS One 6:e14571.
41. Borda, E. S., et al. 1991. Trypanosoma cruzi attachment to lymphocyte muscarinic cholinergic and beta adrenergic receptors modulates intracellular signal transduction. Mol. Biochem. Parasitol. 47:91-100.
42. Braga, M. S., L. Lauria-Pires, E. R. Arganaraz, R. J. Nascimento, and A. R. Teixeira. 2000. Persistent infections in chronic Chagas' disease patients treated with anti-Trypanosoma cruzi nitroderivatives. Rev. Inst. Med. Trop. Sao Paulo 42:157-161.
43. Brener, Z., and E. Chiari. 1965. Aspects of early growth of different T. cruzi strains in culture medium. J. Parasitol. 51:922-926.
44. Brener, Z., Z. A. Andrade, and M. Barral-Neto. 2000. Trypanosoma cruzi and Chagas disease, 2nd ed. Guanabara Koogan, Rio de Janeiro, Brazil.
45. Bringaud, F., et al. 1998. Conserved organization of genes in trypanosomatids. Mol. Biochem. Parasitol. 94:249-264.
46. Bringaud, F., E. Ghedin, N. M. El-Sayed, and B. Papadopoulou. 2008. Role of transposable elements in trypanosomatids. Microbes Infect. 10:575-581.
47. Brown, D., and G. L. Waneck. 1992. Glycosyl-phosphatidylinositol-anchored membrane proteins. J. Am. Soc. Nephrol. 3:895-906.
48. Brown, E. L., et al. 18 December 2009, Posting date. Seroprevalence of Trypanosoma cruzi among eleven potential reservoir species from six states across the Southern United States. Vector Borne Zoonotic Dis. doi: 10.1089/vbz.2009.0009.
49. Burleigh, B. A., and A. M. Woolsey. 2002. Cell signaling and Trypanosoma cruzi invasion. Cell. Microbiol. 4:701-711.
50. Burnet, M. 1972. Auto-immunity and auto-immune disease. F. A. Davis Company, Philadelphia, PA.
51. Caler, E. V., S. Vaena de Avalos, P. A. Haynes, N. W. Andrews, and B. A. Burleigh. 1998. Oligopeptidase B-dependent signaling mediates host cell invasion by Trypanosoma cruzi. EMBO J. 17:4975-4986.
52. Campbell, D. C., and N. R. Sturm. 2009. Trypanosoma cruzi nuclear DNA and its correlation with the parasite lifecycle, p. 70-82. In A. R. L. Teixeira, M. C. Vinaud, and A. M. Castro (ed.), Emerging Chagas disease, 1st ed. Bentham Science Publishers, New York, NY.
53. Campbell, D., S. Thomas, and N. R. Sturm. 2003. Transcription in the kinetoplastid protozoa: why be normal? Microbes Infect. 5:1231-1240.
54. Candolfi, E., C. A. Hunter, and J. S. Remington. 1995. Roles of gamma interferon and other cytokines in suppression of the spleen cell proliferative response to concanavalin A and toxoplasma antigen during acute toxoplasmosis. Infect. Immun. 63:751-756.
55. Cardinal, M. V., et al. 2008. Molecular epidemiology of domestic and sylvatic Trypanosoma cruzi infection in rural northwestern Argentina. Int. J. Parasitol. 38:1533-1543.
56. Cardoni, R. L., R. Docampo, and A. M. Casellas. 1982. Metabolic requirements for the damage of Trypanosoma cruzi epimastigotes by human polymorphonuclear leukocytes. J. Parasitol. 68:547-552.
57. Carvalho, L. O., et al. 2009. Trypanosoma cruzi and myoid cells from seminiferous tubules: interaction and relation with fibrous components of extracellular matrix in experimental Chagas' disease. Int. J. Exp. Pathol. 90:52-57.
58. Cavalier-Smith, T. 2002. The phagotrophic origin of eukaryotes and phylogenetic classification of protozoa. Int. J. Syst. Evol. Microbiol. 52:297-354.
59. Cavalier-Smith, T. 2009. Predation and eukaryote cell origins: a coevolutionary perspective. Int. J. Biochem. Cell Biol. 41:307-322.
60. Cavalier-Smith, T. 2010. Deep phylogeny, ancestral groups and the four ages of life. Philos. Trans. R. Soc. Lond. B Biol. Sci. 365:111-132.
61. Cavalier-Smith, T. 2010. Origin of the cell nucleus, mitosis and sex: roles of intracellular coevolution. Biol. Direct 5:77-85.
62. Cenini, P., N. Berhe, A. Hailu, K. McGinnes, and D. Frommel. 1993. Mononuclear cell subpopulations and cytokine levels in human visceral leishmaniasis before and after chemotherapy. J. Infect. Dis. 168:986-993.
63. Chagas, C. 1909. New human trypanosomiasis. Morphology and lifecycle of Schizotrypanum cruzi, the cause of a new human disease. Mem. Inst. Oswaldo Cruz 1:159-218.
64. Chagas, C. 1910. Nova entidade mórbida do homem. Arch. Soc. Méd. Cirurg. S. Paulo 1:255-292.
65. Chagas, C. 1911. A new human disease. Summary of ethiological and clinical studies. Mem. Inst. Oswaldo Cruz 3:219-275.
66. Chagas, C. 1912. Sobre um trypanosoma do tatú. Tatusia novemcineta, transmitido pelo Triatoma geniculata Latr. (1811). Possibilidade de ser o tatú um depositário do Trypanosoma cruzi no mundo exterior. Bras. Med. 26:305-306.
67. Chagas, C. 1934. Estado actual da tripanossomíase Americana. Rev. Biol. Hyg. 5:58-64.
68. Chagas, C. 1916. Tripanosomiaze Americana. Forma aguda da moléstia. Mem. Inst. Oswaldo Cruz 8:37-65.
69. Chagas, C., and E. Villela. 1922. Forma cardíaca da Tripanosomiase Americana. Mem. Inst. Oswaldo Cruz 14:5-61.
70. Chamizo, C., J. Moreno, and J. Alvar. 2005. Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis. Vet. Immunol. Immunopathol. 103:67-75.
71. Chen, G. L., and J. T. Prchal. 2007. X-linked clonality testing: interpretation and limitations. Blood 110:1411-1419.
72. Chen, S. T., et al. 2008. CLEC5A is critical for dengue-virus-induced lethal disease. Nature 453:672-676.
73. Cihakova, D., and N. R. Rose. 2008. Pathogenesis of myocarditis and dilated cardiomyopathy. Adv. Immunol. 99:95-114.
74. Cillari, E., et al. 1995. In vivo and in vitro cytokine profiles and mononuclear cell subsets in Sicilian patients with active visceral leishmaniasis. Cytokine 7:740-745.
75. Coffman, R. L. 2010. Immunology: the origin of TH2 responses. Science 328:1116-1117.
76. Coura, J. R. 2006. Transmission of chagasic infection by oral route in the natural history of Chagas disease. Rev. Soc. Bras. Med. Trop. 39(Suppl. 3):113-117.
77. Coura, J. R., A. C. V. Junqueira, O. Fernades, S. A. S. Valente, and M. A. Miles. 2002. Emerging Chagas disease in Amazonian Brazil. Trends Parasitol. 18:171-176.
78. Covo, S., J. P. de Villartay, P. A. Jeggo, and Z. Livneh. 2009. Translesion DNA synthesis-assisted non-homologous end-joining of complex doublestrand breaks prevents loss of DNA sequences in mammalian cells. Nucleic Acids Res. 37:6737-6745.
79. Crane, M. S., and J. A. Dvorak. 1979. Trypanosoma cruzi: interaction with vertebrate cells. DNA synthesis and growth of intracellular amastigotes and their relationship to host cell DNA synthesis and growth. J. Protozool. 26:599-604.
80. Cruz-Chan, J. V., et al. 2009. Immunopathology of natural infection with Trypanosoma cruzi in dogs. Vet. Parasitol. 162:151-155.
81. Cubillos-Garzon, L. A., J. P. Casas, C. A. Morillo, and L. E. Bautista. 2004. Congestive heart failure in Latin America: the next epidemic. Am. Heart J. 147:412-417.
82. Cunha-Neto, E., et al. 2006. Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity 39:41-54.
83. Cunha-Neto, E., and J. Kalil. 2001. Heart-infiltrating and peripheral T cells in the pathogenesis of human Chagas' disease cardiomyopathy. Autoimmunity 34:187-192.
84. Cunha-Neto, E., et al. 2009. Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy. Mem. Inst. Oswaldo Cruz 104(Suppl. 1):252-258.
85. Cunha-Neto, E., et al. 1995. Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proc. Natl. Acad. Sci. U. S. A. 92:3541-3545.
86. Cunningham, D. S., T. E. Brewer, R. E. Kuhn, and W. H. Craig. 1981. Partial characterization of a Trypanosoma cruzi-released decomplementing factor. J. Parasitol. 67:475-480.
87. Cunningham, D. S., W. H. Craig, and R. E. Kuhn. 1978. Reduction of complement levels in mice infected with Trypanosoma cruzi. J. Parasitol. 64:1044-1049.
88. Da-Cruz, A. M., et al. 2004. Long-term follow-up of co-infected HIV and Trypanosoma cruzi Brazilian patients. Trans. R. Soc. Trop. Med. Hyg. 98:728-733.
89. da Mata, J. R., E. R. S. Camargos, E. Chiari, and C. R. S. Machado. 2000. Trypanosoma cruzi infection and the rat central nervous system: proliferation of parasites in astrocytes and the brain reaction to parasitism. Brain Res. Bull. 53:153-162.
90. da Matta Guedes, P. M., et al. 2010. IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis. PLoS Negl. Trop. Dis. 4:e604.
91. Daniels, M. D., K. V. Hyland, K. Wang, and D. M. Engman. 2008. Recombinant cardiac myosin fragment induces experimental autoimmune myocarditis via activation of Th1 and Th17 immunity. Autoimmunity 41:490-499.
92. Das, A., M. Banday, and V. Bellofatto. 2008. RNA polymerase transcription machinery in trypanosomes. Eukaryot. Cell 7:429-434.
93. Davila, D. F. 2004. Sympathetic nervous system activation in chagasic patients with congestive heart failure. J. Am. Coll. Cardiol. 43:1723-1724.
94. Dávila, D. F., J. H. Donis, A. Torres, and J. A. Ferrer. 2004. A modified and unifying neurogenic hypothesis can explain the natural history of chronic Chagas heart disease. Int. J. Cardiol. 96:191-195.
95. Dávila, D. F., et al. 2008. Beta-adrenergic blockers in chronic systolic heart failure secondary to Chagas' disease. Int. J. Cardiol. 128:1-4.
96. Dávila, D. F., et al. 2008. Anti-muscarinic autoantibodies and vagal modulation in Chagas disease: positive allosteric modulators vs desensitization and downregulation of M2 cardiac acetylcholine receptors. Int. J. Cardiol. 123:328-329.
97. Dávila, D. F., T. J. Núñez, R. Odreman, and C. A. de Dávila. 2005. Mechanisms of neurohormonal activation in chronic congestive heart failure: pathophysiology and therapeutic implications. Int. J. Cardiol. 101:343-346.
98. de Alencar, B. C., et al. 2009. Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination. Infect. Immun. 77:4383-4395.
99. Deane, M. P., H. L. Lenzi, and A. M. Jansen. 1986. Double development cycle of Trypanosoma cruzi in the opossum. Parasitol. Today 2:146-147.
100. Decottignies, A. 2007. Microhomology-mediated end joining in fission yeast is repressed by pku70 and relies on genes involved in homologous recombination. Genetics 176:1403-1415.
101. Deem, S. L., et al. 2009. Health assessment of free-ranging three-banded (Tolypeutes matacus) and nine-banded (Dasypus novemcinctus) armadillos in the Gran Chaco, Bolivia. J. Zoo Wildl. Med. 40:245-256.
102. de Meis, J., A. Morrot, D. A. Farias-de-Oliveira, D. M. Villa-Verde, and W. Savino. 2009. Differential regional immune response in Chagas disease. PLoS Negl. Trop. Dis. 3:e417.
103. de Souza, W. 2009. Structural organization of Trypanosoma cruzi. Mem. Inst. Oswaldo Cruz 104:89-100.
104. de Souza, W., and D. P. Cavalcanti. 2008. DNA-containing organelles in pathogenic protozoa: a review. Trends Cell. Mol. Biol. 2:89-104.
105. de Souza, W., and H. Meyer. 1974. On the fine structure of the nucleus in Trypanosoma cruzi in tissue culture forms. Spindle fibers in the dividing nucleus. J. Protozool. 21:48-52.
106. de Thoisy, B., J. C. Michel, I. Vogel, and J. C. Vié. 2000. A survey of hemoparasite infections in free-ranging mammals and reptiles in French Guiana. J. Parasitol. 86:1035-1040.
107. Dias, E. 1944. Non-receptivity of the domestic pigeon to the Schizotrypanum infection. Mem. Inst. Oswaldo Cruz 40:181.
108. Dias, E. 1952. Chagas' disease in the Americas. IV. Colombia, Venezuela and the Guianas. Rev. Bras. Malariol. Doencas Trop. 4:255-280.
109. Dias, E. 1953. Chagas disease in the Americas. VII. Chile. Rev. Bras. Malariol. Doencas Trop. 5:131-136.
110. Dias, E., F. S. Laranja, A. Miranda, and G. Nobrega. 1956. Chagas disease; a clinical, epidemiologic, and pathologic study. Circulation 14:1035-1060.
111. Dias, J. C. P., and J. C. Schofiel. 2009. History of Chagas disease as a public health problem in Latin America, p. 1-9. In A. R. L. Teixeira, M. C. Vinaud, and A. M. Castro (ed.), Emerging Chagas disease, 1st ed. Bentham Science Publishers, New York, NY.
112. Diotaiuti, L. 2009. Triatomine-vector of Trypanosoma cruzi infection, p. 24-39. In A. R. L. Teixeira, M. C. Vinaud, and A. M. Castro (ed.), Emerging Chagas disease, 1st ed. Bentham Science Publishers, New York, NY.
113. Dittmar, K. 2002. Arthropod and helminth parasites of the wild guinea pig, Cavia aperea, from the Andes and the cordillera in Peru, South America. J. Parasitol. 88:409-411.
114. Dittmar, K., A. M. Jansen, A. Araújo, and K. Reinhard. 2003. Molecular diagnosis of prehistoric T. cruzi in the Texas-Coahuila border region. Thirteenth Annual Meeting of the Paleopathology Association, Tempe, Arizona. Paleopathol. News 1:4.
115. Dolezel, D., M. Jirku, D. A. Maslov, and J. Lukes. 2000. Phylogeny of the bodonid flagellates (Kinetoplastida) based on small-subunit rRNA gene sequences. Int. J. Syst. Evol. Microbiol. 50:1943-1951.
116. Dominical, V. M., et al. 2010. Chagas disease and gynecologic neoplasias. Ann. Diagn. Pathol. 14:337-340.
117. Dong, C., T. Poulter, and J. S. Han. 2009. LINE-like retrotransposition in Saccharomyces cerevisiae. Genetics 181:301-311.
118. Doolitle, W. F. 1998. A paradigm gets shifty. Nature 392:15-16.
119. dos Reis, F. C., et al. 2008. The role of conserved residues of chagasin in the inhibition of cysteine peptidases. FEBS Lett. 582:485-490.
120. Doyle, P. S., I. Hsieh, and J. C. Engel. 2000. Trypanosoma cruzi: of man, kissing-bugs, and frogs. Exp. Parasitol. 95:71-74.
121. Dutra, W. O., et al. 1997. Cytokine mRNA profile of peripheral blood mononuclear cells isolated from individuals with Trypanosoma cruzi chronic infection. Scand. J. Immunol. 45:74-80.
122. Dvorak, J. A. 1984. The natural heterogeneity of Trypanosoma cruzi: biological and medical implications. J. Cell. Biochem. 24:357-371.
123. Dvorak, J. A., et al. 1982. Trypanosoma cruzi: flow cytometric analysis. I. Analysis of total DNA/organism by means of mithramycin-induced fluorescence. J. Protozool. 29:430-437.
124. Elias, M. C., R. Marques-Porto, E. Freymuller, and S. Schenckman. 2001. Transcription rate modulation through the Trypanosoma cruzi life cycle occurs in parallel with changes in nuclear organization. Mol. Biochem. Parasitol. 112:79-90.
125. El-Sayed, N. M., et al. 2005. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 309:409-415.
126. Engman, D. M., and J. S. Leon. 2002. Pathogenesis of Chagas heart disease: role of autoimmunity. Acta Trop. 81:123-132.
127. Epting, C. L., B. M. Coates, and D. M. Engman. 18 June 2010, Posting date. Molecular mechanisms of host cell invasion by Trypanosoma cruzi. Exp. Parasitol. doi:10.1016/j.exppara.2010.06.023.
128. Epting, C. L., M. Bonney, C. L. Olson, and D. M. Engman. 2009. Cellular host-pathogen relationships, p. 83-93. In A. R. L. Teixeira, M. C. Vinaud, and A. M. Castro (ed.), Emerging Chagas disease, 1st ed. Bentham Science Publishers, New York, NY.
129. Fairweather, D., S. Frisancho-Kiss, and N. R. Rose. 2005. Viruses as adjuvants for autoimmunity: evidence from coxsackievirus-induced myocarditis. Rev. Med. Virol. 15:17-27.
130. Fairweather, D., et al. 2004. Mast cells and innate cytokines are associated with susceptibility to autoimmune heart disease following coxsackievirus B3 infection. Autoimmunity 37:131-145.
131. Fairweather, D., et al. 2003. IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta-and IL-18-associated myocarditis and coxsackievirus replication. J. Immunol. 170:4731-4737.
132. Felix, J. C., B. F. von Kreuter, and C. A. Santos-Buch. 1993. Mimicry of heart cell surface epitopes in primary anti-Trypanosoma cruzi Lyt 2+ T lymphocytes. Clin. Immunol. Immunopathol. 68:141-146.
133. Feng, Q., J. V. Moran, H. H. Kazazian, and J. D. Boeke. 1996. Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell 87:905-916.
134. Ferguson, M. A., and G. M. A. Cross. 1984. Myristylation of the membrane form of a Trypanosoma brucei variant surface glycoprotein. J. Biol. Chem. 259:3011-3015.
135. Ferguson, M. A., et al. 1994. Glycosyl-phosphatidylinositol molecules of the parasite and the host. Parasitol. 108(Suppl.):S45-S54.
136. Fernandes, M. C., et al. 2007. Novel strategy in Trypanosoma cruzi cell invasion: implication of cholesterol and host cell microdomains. Int. J. Parasitol. 37:1431-1441.
137. Field, M. C., E. Medina-Acosta, and G. A. Cross. 1991. Characterization of a glycosylphosphatidylinositol membrane protein anchor precursor in Leishmania mexicana. Mol. Biochem. Parasitol. 48:227-229.
138. Flynn, J. J., and A. R. Wyss. 1998. Recent advances in South American mammalian paleontology. Tree 13:449-454.
139. Forero, D., C. Weirauch, and M. Baena. 2004. Synonymy of the reduviid (Hemiptera: Heteroptera) genus Torrealbaia (Triatominae) with Amphibolus (Harpactorinae), with notes on Amphibolus venator (Klug, 1830). Zootaxa 670:1-12.
140. Fortes-Rego, J., V. O. Macedo, and A. R. Prata. 1980. Alterac ̧o ̃es neurológicas na doenc ̧a de Chagas crǒnica. Arq. Neuropsi. 38:45-52.
141. Francis, J., V. Sankar, V. K. Nair, and S. G. Priori. 2005. Catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2:550-554.
142. Freire-de-Lima, L., et al. 2010. Trypanosoma cruzi subverts host cell sialylation and may compromise antigen-specific CD8+ T cell responses. J. Biol. Chem. 285:13388-13396.
143. Galuppo, S., et al. 2009. Predominance of Trypanosoma cruzi genotypes in two reservoirs infected by sylvatic Triatoma infestans of an endemic area of Chile. Acta Trop. 111:90-93.
144. Gantt, K. R., et al. 2003. Activation of TGF-beta by Leishmania chagasi: importance for parasite survival in macrophages. J. Immunol. 170:2613-2620.
145. Gardner, T. A., et al. 2008. The cost-effectiveness of biodiversity surveys in tropical forests. Ecol. Lett. 11:139-150.
146. Gaunt, M. W., and M. A. Miles. 2002. An insect molecular clock dates the origin of the insects and accords with palaeontological and biogeographic landmarks. Mol. Biol. Evol. 19:748-761.
147. Geer, D. A. 1955. Found: two cases of Chagas disease. Texas Health Bull. 9:11.
148. Ghedin, E., et al. 2004. Gene synteny and evolution of genome architecture in trypanosomatids. Mol. Biochem. Parasitol. 134:183-191.
149. Gilbert, C., S. Schaack, J. K. Pace, P. J. Brindley, and C. Feschotte. 2010. A role for host-parasite interactions in the horizontal transfer of transposons across phyla. Nature 464:1347-1350.
150. Gironés, N., et al. 2001. Antibodies to an epitope from the Cha human autoantigen are markers of Chagas' disease. Clin. Diagn. Lab. Immunol. 8:1039-1043.
151. Gironés, N., et al. 2001. Dominant T-and B-cell epitopes in an autoantigen linked to Chagas' disease. J. Clin. Invest. 107:985-993.
152. Gironés, N., et al. 2007. Role of Trypanosoma cruzi autoreactive T cells in the generation of cardiac pathology. Ann. N. Y. Acad. Sci. 1107:434-444.
153. Gironés, N., H. Cuervo, and M. Fresno. 2005. Trypanosoma cruzi-induced molecular mimicry and Chagas' disease. Curr. Top. Microbiol. Immunol. 296:89-123.
154. Glück, B., M. Schmidtke, I. Merkle, A. Stelzner, and D. Gemsa. 2001. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice. J. Mol. Cell. Cardiol. 33:1615-1626.
155. Goble, F. C., and J. L. Boyd. 1962. Reticulo-endothelial blockade in experimental Chagas' disease. J. Parasitol. 48:223-228.
156. Godsel, L. M., et al. 2001. Prevention of autoimmune myocarditis through the induction of antigen-specific peripheral immune tolerance. Circulation 103:1709-1714.
157. Gomes, Y. M., et al. 1995. A monoclonal antibody against blood forms of Trypanosoma cruzi lyses the parasite in vitro and inhibits host cell invasion. Appl. Biochem. Biotechnol. 50:57-69.
158. Gopal, S., G. A. Cross, and T. Gaasterland. 2003. An organism-specific method to rank predicted coding regions in Trypanosoma brucei. Nucleic Acids Res. 31:5877-5885.
159. Goronzy, J. J., and C. M. Weyand. 2009. Developments in the scientific understanding of rheumatoid arthritis. Arthritis Res. Ther. 11:249.
160. Goto, H., and M. G. Prianti. 2009. Immunoactivation and immunopathogeny during active visceral leishmaniasis. Rev. Inst. Med. Trop. Sao Paulo 51:241-246.
161. Guedes, P. M., et al. 2009. Development of chronic cardiomyopathy in canine Chagas disease correlates with high IFN-gamma, TNF-alpha, and low IL-10 production during the acute infection phase. Vet. Immunol. Immunopathol. 130:43-52.
162. Guerra, F. 1970. American trypanosomiasis. A historical and a humanlesson. J. Trop. Med. Hyg. 73:105-118.
163. Günzl, A. 2010. The pre-mRNA splicing machinery of trypanosomes: complex or simplified? Eukaryot. Cell 9:1159-1170.
164. Gürtler, R. E., et al. 2009. Strong host-feeding preferences of the vector Triatoma infestans modified by vector density: implications for the epidemiology of Chagas disease. PLoS Negl. Trop. Dis. 3:e447.
165. Gutierrez, F. R. S., P. M. M. Guedes, R. T. Gazzinelli, and J. S. Silva. 2009. The role of parasite persistence in pathogenesis of Chagas heart disease. Parasite Immunol. 31:673-685.
166. Hagger, R., et al. 2000. A deficiency of interstitial cells of Cajal in Chagasic megacolon. J. Auton. Nerv. Syst. 80:108-111.
167. Hamilton, P. B., W. C. Gibson, and J. R. Stevens. 2007. Patterns of co-evolution between trypanosomes and their hosts deduced from ribosomal RNA and protein-coding gene phylogenies. Mol. Phylogenet. Evol. 44:15-25.
168. Harms, G., and H. Feldmeier. 2005. The impact of HIV infection on tropical diseases. Infect. Dis. Clin. North Am. 19:121-135.
169. Harris, T. H., et al. 2010. NF-kappaB1 contributes to T cell-mediated control of Toxoplasma gondii in the CNS. J. Neuroimmunol. 222:19-28.
170. Hatcher, F. M., and R. E. Kuhn. 1982. Destruction of Trypanosoma cruzi by natural killer cells. Science 218:295-296.
171. Hatcher, F. M., R. E. Kuhn, M. C. Cerrone, and R. C. Burton. 1981. Increased natural killer cell activity in experimental American trypanosomiasis. J. Immunol. 127:1126-1130.
172. Hazkani-Covo, E., and S. Covo. 2008. Numt-mediated double-strand break repair mitigates deletions during primate genome evolution. PLoS Genet. 4:e1000237.
173. Hecht, M. M., et al. 2010. Inheritance of DNA transferred from American trypanosomes to human hosts. PLoS One 5:e9181.
174. Hecht, M. M., A. C. Bussacos, S. P. Lozzi, J. M. Santana, and A. R. Teixeira. 2006. Triatoma infestans chooses to feed upon immune prey. Am. J. Trop. Med. Hyg. 75:893-900.
175. Hecht, M. M., N. Nitz, P. F. Araujo, and A. R. L. Teixeira. 2009. Pathogenesis of Chagas disease: lateral DNA transfer, genotype alterations and autoimmunity. Rev. Soc. Bras. Med. Trop. 42(Suppl.):87-93.
176. Heras, S. R., M. C. Lopez, M. Olivares, and M. C. Thomas. 2007. The L1Tc non-LTR retrotransposon of Trypanosoma cruzi contains an internal RNApol II-dependent promoter that strongly activates gene transcription and generates unspliced transcripts. Nucleic Acids Res. 35:2199-2214.
177. Herrera, H. M., et al. 2008. The coati (Nasua nasua, Carnivora, Procyonidae) as a reservoir host for the main lineages of Trypanosoma cruzi in the Pantanal region, Brazil. Trans. R. Soc. Trop. Med. Hyg. 102:1133-1139.
178. Hertz-Fowler, C., et al. 2004. GeneDB: a resource for prokaryotic and eukaryotic organisms. Nucleic Acids Res. 32:D339-D343.
179. Hines, J. C., and D. S. Ray. 2008. Structure of discontinuities in kinetoplast DNA-associated minicircles during S phase in Crithidia fasciculata. Nucleic Acids Res. 36:444-450.
180. Hoff, R., et al. 1985. Serologic surveillance of Chagas disease. Ann. Soc. Belg. Med. Trop. 65:187-196.
181. Huber, S. A., and B. Pfaeffle. 1994. Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3. J. Virol. 68:5126-5132.
182. Hyde, T. P., and J. A. Dvorak. 1973. Trypanosoma cruzi: interaction with vertebrate cells in vitro. 2. Quantitative analysis of the penetration phase. Exp. Parasitol. 34:284-294.
183. Hyland, K. V., and D. M. Engman. 2006. Further thoughts on where we stand on the autoimmunity hypothesis of Chagas disease. Trends Parasitol. 22:101-102.
184. Hyland, K. V., et al. 2007. Modulation of autoimmunity by treatment of an infectious disease. Infect. Immun. 75:3641-3650.
185. Inglessis, I., et al. 1998. Clinical, parasitological and histopathologic follow-up studies of acute Chagas patients treated with benznidazole. Arch. Inst. Cardiol. Mex. 68:405-410.
186. Invernizzi, P., S. Pasini, C. Selmi, M. Miozzo, and M. Podda. 2008. Skewing of X chromosome inactivation in autoimmunity. Autoimmunity 41:272-277.
187. Inverso, J. A., Y. Song, and C. A. Santos-Buch. 1995. Plasma membrane ATP receptors in Trypanosoma cruzi trypomastigotes. Receptor 5:197-206.
188. Ivens, A. C., et al. 2005. The genome of the kinetoplastid parasite, Leishmania major. Science 309:436-442.
189. Iwai, L. K., M. A. Juliano, L. Juliano, J. Kalil, and E. Cunha-Neto. 2005. T-cell molecular mimicry in Chagas disease: identification and partial structural analysis of multiple cross-reactive epitopes between Trypanosoma cruzi B13 and cardiac myosin heavy chain. J. Autoimmun. 24:111-117.
190. James, S., T. Kipnis, A. Sher, and R. Hoff. 1982. Enhanced resistance to acute infection with Trypanosoma cruzi in mice with an interferon inducer. Infect. Immun. 35:588-593.
191. Januszyk, K., et al. 2007. Identification and solution structure of a highly conserved C-terminal domain required for the retrotransposition of long interspersed nuclear element-1. J. Biol. Chem. 282:24893-24904.
192. Johnson, P. J., J. M. Kooter, and P. Borst. 1987. Inactivation of transcription by UV irradiation of T. brucei provides evidence for a multicistronic transcription unit including a VSG gene. Cell 51:273-281.
193. Junqueira, L. F., Jr., and J. D. Soares. 2002. Impaired autonomic control of heart interval changes to Valsalva manoeuvre in Chagas' disease without overt manifestation. Auton. Neurosci. 97:59-67.
194. Jurka, J. 1997. Sequence patterns indicate an enzymatic involvement in integration of mammalian retroposons. Proc. Natl. Acad. Sci. U. S. A. 94:1872-1877.
195. Kallinikova, V. D., et al. 2001. Anticancer properties of flagellate protozoan Trypanosoma cruzi Chagas. Izv. Akad. Nauk. SSSR Biol. 3:299-311.
196. Karakhanova, S., S. Meisel, S. Ring, K. Mahnke, and A. H. Enk. 2010. ERK/p38 MAP-kinases and PI3K are involved in the differential regulation of B7-H1 expression in DC subsets. Eur. J. Immunol. 40:254-266.
197. Kenworthy, A. K., et al. 2004. Dynamics of putative raft-associated proteins at the cell surface. J. Cell Biol. 165:735-746.
198. Kierszenbaum, F. 1996. Chronic chagasic tissue lesions in the absence of Trypanosoma cruzi: a proposed mechanism. Parasitol. Today 12:414-415.
199. Kierszenbaum, F. 1999. Chagas' disease and the autoimmunity hypothesis. Clin. Microbiol. Rev. 12:210-223.
200. Kierszenbaum, F. 2003. Views on the autoimmunity hypothesis for Chagas disease pathogenesis. FEMS Immunol. Med. Microbiol. 37:1-11.
201. Kierszenbaum, F. 2005. Where do we stand on the autoimmunity hypothesis of Chagas disease? Trends Parasitol. 21:513-516.
202. Kierszenbaum, F., and G. Sonnenfeld. 1982. Characterization of the antiviral activity produced during Trypanosoma cruzi infection and protective effects of exogenous interferon against experimental Chagas' disease. J. Parasitol. 68:194-198.
203. Kierszenbaum, F., and M. M. Pienkowski. 1979. Thymus-dependent control of host defense mechanisms against Trypanosoma cruzi infection. Infect. Immun. 24:117-120.
204. Kierszenbaum, F., C. A. Gottlieb, and D. B. Budzko. 1981. Antibodyindependent, natural resistance of birds to Trypanosoma cruzi infection. J. Parasitol. 67:656-660.
205. Kierszenbaum, F., J. Ivanyi, and D. B. Budzko. 1976. Mechanisms of natural resistance to trypanosomal infection. Role of complement in avian resistance to Trypanosoma cruzi infection. Immunology 30:1-6.
206. Kim, H. B., I. Evans, R. Smallwood, M. Holcombe, and E. E. Qwarnstrom. 2010. NIK and IKKbeta interdependence in NF-kappaB signalling-flux analysis of regulation through metabolites. Biosystems 99:140-149.
207. Kimura, M. 1983. From Lamarck to population genetics, p. 1-14. In M. Kimura (ed.), The neutral theory of molecular evolution, 1st ed. Cambridge University Press, New York, NY.
208. Kipnis, T. L., J. R. David, C. A. Alper, A. Sher, and W. D. da Silva. 1981. Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophages. Proc. Natl. Acad. Sci. U. S. A. 78:602-605.
209. Kipnis, T. L., S. L. James, A. Sher, and J. R. David. 1981. Cell-mediated cytotoxicity to Trypanosoma cruzi. II. Antibody-dependent killing of bloodstream forms by mouse eosinophils and neutrophils. Am. J. Trop. Med. Hyg. 30:47-53.
210. Kivity, S., N. Agmon-Levin, M. Blank, and Y. Shoenfeld. 2009. Infections and autoimmunity-friends or foes? Trends Immunol. 30:409-414.
211. Knipe, D. M., and P. M. Howley (ed.). 2007. Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
212. Koeberle, F. 1963. Etiologia e patogenia do megaesǒfago no Brasil. Rev. Goiana Med. 9:79-116.
213. Koeberle, F. 1970. The causation and importance of nervous lesions in American trypanosomiasis. Bull. World Health Organ. 42:739-743.
214. Korený, L., J. Lukes, and M. Oborník. 2010. Evolution of the haem synthetic pathway in kinetoplastid flagellates: an essential pathway that is not essential after all? Int. J. Parasitol. 40:149-156.
215. Kress, Y., B. R. Bloom, M. Whitner, A. Rowen, and H. Tanowitz. 1975. Resistance of Trypanosoma cruzi to killing by macrophages. Nature 257: 394-396.
216. Krettli, A. U. 2009. The utility of anti-trypomastigote lytic antibodies for determining cure of Trypanosoma cruzi infections in treated patients: an overview and perspectives. Mem. Inst. Oswaldo Cruz 104(Suppl. 1):142-151.
217. Kuhn, R. E., and S. K. Durum. 1975. The onset of immune protection in acute experimental Chagas' disease in C3H(HE) mice. Int. J. Parasitol. 5:241-244.
218. Kumar, R., I. K. Kline, and W. H. Abelmann. 1970. Immunosuppression in experimental acute and subacute Chagasic myocarditis. Am. J. Trop. Med. Hyg. 19:932-939.
219. Lages-Silva, E., et al. 2001. Relationship between Trypanosoma cruzi and human chagasic megaesophagus: blood and tissue parasitism. Am. J. Trop. Med. Hyg. 65:435-441.
220. Laguens, R. P., et al. 1975. Immunopathologic and morphologic studies of skeletal muscle in Chagas' disease. Am. J. Pathol. 80:153-162.
221. Lake, J. A., V. F. de la Cruz, P. C. Ferreira, C. Morel, and L. Simpson. 1988. Evolution of parasitism: kinetoplastid protozoan history reconstructed from mitochondrial rRNA gene sequences. Proc. Natl. Acad. Sci. U. S. A. 85: 4779-4783.
222. Lang, C., et al. 2008. Connective tissue growth factor: a crucial cytokinemediating cardiac fibrosis in ongoing enterovirus myocarditis. J. Mol. Med. 86:49-60.
223. Laranja, F. S. 1949. Evoluc ̧a ̃o dos conhecimentos sobre a cardiopatia chagásica. Revisa ̃o crítica da literatura. Mem. Inst. Oswaldo Cruz 47:605-669.
224. Laucella, S. A., et al. 2009. Changes in Trypanosoma cruzi-specific immune responses after treatment: surrogate markers of treatment efficacy. Clin. Infect. Dis. 49:1675-1684.
225. Lauria-Pires, L., et al. 2000. Progressive chronic Chagas heart disease ten years after treatment with anti-Trypanosoma cruzi nitroderivatives. Am. J. Trop. Med. Hyg. 63:111-118.
226. Lee, J. H., H. S. Jung, and A. Gunzl. 2009. Transcriptionally active TFIIH of the early-diverged eukaryote Trypanosoma brucei harbors two novel core subunits but not a cyclin-activating kinase complex. Nucleic Acids Res. 37:3811-3820.
227. Lee, J., et al. 2007. Different evolutionary fates of recently integrated human and chimpanzee LINE-1 retrotransposons. Gene 390:18-27.
228. Leon, J. S., and D. M. Engman. 2001. Autoimmunity in Chagas heart disease. Int. J. Parasitol. 31:555-561.
229. Leon, J. S., and D. M. Engman. 2003. The significance of autoimmunity in the pathogenesis of Chagas heart disease. Front. Biosci. 8:e315-e322.
230. Leon, J. S., K. Wang, and D. M. Engman. 2003. Myosin autoimmunity is not essential for cardiac inflammation in acute Chagas' disease. J. Immunol. 171:4271-4277.
231. Leon, J. S., L. M. Godsel, K. Wang, and D. M. Engman. 2001. Cardiac myosin autoimmunity in acute Chagas' heart disease. Infect. Immun. 69: 5643-5649.
232. Leon, J. S., M. D. Daniels, K. M. Toriello, K. Wang, and D. M. Engman. 2004. A cardiac myosin-specific autoimmune response is induced by immunization with Trypanosoma cruzi proteins. Infect. Immun. 72:3410-3417.
233. Levin, M. J. 1996. In chronic Chagas heart disease, don't forget the parasite. Parasitol. Today 12:415-416.
234. Lewis, M. D., et al. 2009. Flow cytometric analysis and microsatellite genotyping reveal extensive DNA content variation in Trypanosoma cruzi populations and expose contrasts between natural and experimental hybrids. Int. J. Parasitol. 39:1305-1317.
235. Li, K., et al. 2009. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis. Circ. Res. 105:353-364.
236. Lieberman, L. A., et al. 2004. IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12. J. Immunol. 173:1887-1893.
237. Lieberman-Aiden, E., et al. 2009. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 326: 289-293.
238. Lima, A. P., et al. 2001. Cysteine protease isoforms from Trypanosoma cruzi, cruzipain 2 and cruzain, present different substrate preference and susceptibility to inhibitors. Mol. Biochem. Parasitol. 114:41-52.
239. Lin, S., Y. L. Huang, W. F. Wu, Y. Li, and S. D. Tang. 2009. Role of interleukin 17 in viral myocarditis and dilated cardiomyopathy. Nan Fang Yi Ke Da Xue Xue Bao 29:1994-1999. (In Chinese.)
240. Lisboa, C. V., S. C. Xavier, H. M. Herrera, and A. M. Jansen. 2009. The ecology of the Trypanosoma cruzi transmission cycle: dispersion of zymodeme 3 (Z3) in wild hosts from Brazilian biomes. Vet. Parasitol. 165:19-24.
241. Lischke, A., et al. 2000. Isolation and characterization of glycosylphosphatidylinositol-anchored, mucin-like surface glycoproteins from bloodstream fo rms of the freshwater-fish parasite Trypanosoma carassii. Biochem. J. 345:693-700.
242. Liu, Y. G., and R. F. Whittier. 1995. Thermal asymmetric interlaced PCR: automatable amplification and sequencing of insert end fragments from P1 and YAC clones for chromosome walking. Genomics 25:674-681.
243. Logan, L. L., and W. L. Hanson. 1974. Trypanosoma cruzi: morphogenesis in diffusion chambers in the mouse peritoneal cavity and attempted stimulation of host immunity. Exp. Parasitol. 36:439-454.
244. Lopes, E. R., E. Chapadeiro, M. C. Borges, M. A. Cançado, and A. Rocha. 1982. Sudden death and Chagas' disease-analysis of predisposing factors of sudden death in chronic Chagas' patients. Mem. Inst. Oswaldo Cruz 77:255-262.
245. López, A. F., M. M. Moreno, and C. J. Sanderson. 1978. The lysis of Trypanosoma cruzi epimastigotes by eosinophils and neutrophils. Int. J. Parasitol. 8:485-489.
246. Lopez Kostka, S., et al. 2009. IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice. J. Immunol. 182:3039-3046.
247. Loudon, R. P., A. F. Moraska, S. A. Huber, P. Schwimmbeck, and P. Schultheiss. 1991. An attenuated variant of coxsackievirus B3 preferentially induces immunoregulatory T cells in vivo. J. Virol. 65:5813-5819.
248. Lugo-Hernández, A. 1973. Morphology of Trypanosoma cruzi in cells of chicken and lizards (Tropidurus hispidus, Sauria: Iguanidae) cultured at 37 degrees and 33 degrees C. Rev. Bras. Biol. 33:561-573.
249. Lukes ̌, J., H. Hashimi, and A. Zíková. 2005. Unexplained complexity of the mitochondrial genome and transcriptome in kinetoplastid flagellates. Curr. Genet. 48:277-299.
250. Lyons, R. E., et al. 2001. Immunological studies of chronic ocular toxoplasmosis: up-regulation of major histocompatibility complex class I and transforming growth factor beta and a protective role for interleukin-6. Infect. Immun. 69:2589-2595.
251. Macedo, V. 1999. Intermediate form of Chagas disease. Mem. Inst. Oswaldo Cruz 94(Suppl. 1):311-316.
252. Machado, C. R., E. R. Camargos, L. B. Guerra, and M. C. Moreira. 2000. Cardiac autonomic denervation in congestive heart failure: comparison of Chagas' heart disease with other dilated cardiomyopathy. Hum. Pathol. 31:3-10.
253. Mady, C., A. V. de Moraes, N. Galiano, and L. V. Decourt. 1982. Hemodynamic study of the intermediate form of Chagas' disease. Arq. Bras. Cardiol. 38:271-275.
254. Mady, C., B. M. Ianni, and J. L. de Souza, Jr. 2008. Benznidazole and Chagas disease: can an old drug be the answer to an old problem? Expert Opin. Invest. Drugs 17:1427-1433.
255. Magalhães-Santos, I. F., and S. G. Andrade. 2005. Participation of cytokines in the necrotic-inflammatory lesions in the heart and skeletal muscles of Calomys callosus infected with Trypanosoma cruzi. Mem. Inst. Oswaldo Cruz 100:555-561.
256. Maisch, B., A. Richter, A. Sandmöller, I. Portig, and S. Pankuweit. 2005. Inflammatory dilated cardiomyopathy (DCMI). Herz 30:535-544.
257. Mandal, P. K., and H. H. Kazazian,. 2008. SnapShot: vertebrate transposons. Cell 135:192-192.e1.
258. Mandison-Antenucci, S., J. Grams, and S. L. Hajduk. 2002. Editing machines: the complexities of trypanosome RNA editing. Cell 108:430-438.
259. Marande, W., J. Lukes, and G. Burger. 2005. Unique mitochondrial genome structure in diplonemids, the sister group of kinetoplastids. Eukaryot. Cell 4:1137-1146.
260. Marcili, A., et al. 2009. Comparative phylogeography of Trypanosoma cruzi TCIIc: new hosts, association with terrestrial ecotopes, and spatial clustering. Infect. Genet. Evol. 9:1265-1274.
261. Marcus, E. 2005. Retraction controversy. Cell 123:173-175.
262. Margulis, L., and D. Sagan. 2002. Acquiring genomes. A theory of the origin of species. Basic Books, New York, NY.
263. Mariner, P. D., et al. 2008. Human Alu RNA is a modular transacting repressor of mRNA transcription during heat shock. Mol. Cell 29:499-509.
264. Marin-Neto, J. A., E. Cunha-Neto, B. C. Maciel, and M. V. Simões. 2007. Pathogenesis of chronic Chagas heart disease. Circulation 115:1109-1123.
265. Marino, A. P., et al. 2005. CC-chemokine receptors: a potential therapeutic target for Trypanosoma cruzi-elicited myocarditis. Mem. Inst. Oswaldo Cruz 100:93-96.
266. Marsden, P. D., and J. W. C. Hagstrom. 1968. Experimental Trypanosoma cruzi infections in beagle puppies. The effect of variations in the dose and source of infecting trypanosomes and the route of inoculation on the course of the infection. Trans. R. Soc. Trop. Med. Hyg. 62:816-824.
267. Martin, D. L., K. Murali-Krishna, and R. L. Tarleton. 2010. Generation of Trypanosoma cruzi-specific CD8+ T-cell immunity is unaffected by the absence of type I interferon signaling. Infect. Immun. 78:3154-3159.
268. Martin, S. L. 2006. The ORF1 protein encoded by LINE-1: structure and function during L1 retrotransposition. J. Biomed. Biotechnol. 2006:1-6.
269. Martínez-Calvillo, S., D. Nguyen, K. Stuart, and P. J. Myler. 2004. Transcription initiation and termination on Leishmania major chromosome 3. Eukaryot. Cell 3:506-517.
270. Martínez-Calvillo, S., et al. 2003. Transcription of Leishmania major Friedlin chromosome 1 initiates in both directions within a single region. Mol. Cell 11:1291-1299.
271. Mathias, C. J. 1997. Autonomic disorders and their recognition. N. Engl. J. Med. 336:721-724.
272. Mathias, S. L., A. F. Scott, H. H. Kazazian, J. D. Boeke, and A. Gabriel. 1991. Reverse transcriptase encoded by a human transposable element. Science 254:1808-1810.
273. Matowicka-Karna, J., V. Dymicka-Piekarska, and H. Kemona. 2009. Does Toxoplasma gondii infection affect the levels of IgE and cytokines (IL-5, IL-6, IL-10, IL-12, and TNF-alpha)? Clin. Dev. Immunol. 2009:374696.
274. Mazza, S. 1995. Cas de trypanosomose humaine observe dans la ville de Jujuy. Compt. Rend. Soc. Biol. 95:815.
275. Mazza, S. 1995. Infeccion spontannée du chien par le Schizotrypanum cruzi. Compt. Rend. Soc. Biol. 270:809-811.
276. Mazza, S. 1951. Exposition of contributions of M.E.P. R. A. to the knowledge of biopathology of Chagas' disease. Sem. Med. 58:296-300.
277. McVey, M., and S. E. Lee. 2008. MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings. Trends Genet. 24:529-538.
278. Meira, W. S., et al. 2006. Evaluation of blood tests, complement-mediated lysis and polymerase chain reaction in the verification of therapeutic efficacy in Chagas disease. Rev. Soc. Bras. Med. Trop. 39(Suppl. 3):107-109.
279. Mendes, D. G., et al. 2007. Exposure to mixed asymptomatic infections with Trypanosoma cruzi, Leishmania braziliensis and Leishmania chagasi in the human population of the greater Amazon. Trop. Med. Int. Health 12:629-636.
280. Meneghelli, U. G., et al. 1982. Basal motility of dilated and non-dilated sigmoid colon and rectum in Chagas' disease. Arq. Gastroenterol. 19:127-132.
281. Meyer, H., M. Oliveira Musacchio, and I. Andrade Mendonça. 1958. Electron microscopy study of Trypanosoma cruzi in thin sections of infected tissue cultures and blood agar forms. Parasitology 48:1-8.
282. Middleton, M. K., et al. 2009. 12/15-lipoxygenase-dependent myeloid production of interleukin-12 is essential for resistance to chronic toxoplasmosis. Infect. Immun. 77:5690-5700.
283. Minter-Goedbloed, E., and J. J. Croon. 1981. The susceptibility of chickens to Trypanosoma (Schizotrypanum) cruzi. Trans. R. Soc. Trop. Med. Hyg. 75:350-353.
284. Moncayo, A., and A. C. Silveira. 2009. Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem. Inst. Oswaldo Cruz 104:17-30.
285. Monteiro, R. V., J. M. Dietz, and A. M. Jansen. 2010. The impact of concomitant infections by Trypanosoma cruzi and intestinal helminths on the health of wild golden and golden-headed lion tamarins. Res. Vet. Sci. 89:27-35.
286. Montoya-Durango, D. E., et al. 2009. Epigenetic control of mammalian LINE-1 retrotransposon by retinoblastoma proteins. Mutat. Res. 665: 20-28.
287. Mordue, D. G., F. Monroy, M. La Regina, C. A. Dinarello, and L. D. Sibley. 2001. Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. J. Immunol. 167:4574-4584.
288. Moretti, E., B. Basso, L. Cervetta, A. Brigada, and G. Barbieri. 2002. Patterns of cytokines and soluble cellular receptors in the sera of children with acute Chagas' disease. Clin. Diagn. Lab. Immunol. 9:1324-1327.
289. Morrish, T. A., et al. 2007. Endonuclease-independent LINE-1 retrotransposition at mammalian telomeres. Nature 446:208-212.
290. Moser, D. R., L. V. Kirchhoff, and J. E. Donelson. 1989. Detection of Trypanosoma cruzi by DNA amplification using the polymerase chain reaction. J. Clin. Microbiol. 27:1477-1482.
291. Muñoz, M., et al. 2009. Interleukin (IL)-23 mediates Toxoplasma gondiiinduced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J. Exp. Med. 206:3047-3059.
292. Nagineni, C. N., B. Detrick, and J. J. Hooks. 2002. Transforming growth factor-beta expression in human retinal pigment epithelial cells is enhanced by Toxoplasma gondii: a possible role in the immunopathogenesis of retinochoroiditis. Clin. Exp. Immunol. 128:372-378.
293. Nery-Guimarães, F., I. Venâncio, and N. Grynberg. 1974. Refractoriness of hens towards Trypanosoma (Schizotrypanum) cruzi. III. Dissociation of phenomena of the refractory state and lysis of the epimastigotes by fowl serum. Mem. Inst. Oswaldo Cruz 72:131-136.
294. Nilsson, D., and B. Andersson. 2005. Strand asymmetry patterns in trypanosomatid parasites. Exp. Parasitol. 109:143-149.
295. Nitz, N., et al. 2004. Heritable integration of kDNA minicircle sequences from Trypanosoma cruzi into the avian genome: insights into human Chagas disease. Cell 118:175-186.
296. Nussenzweig, A., and M. C. Nussenzweig. 2007. A backup DNA repair pathway moves to the forefront. Cell 131:223-225.
297. Obado, S. O., C. Bot, D. Nilsson, B. Andersson, and J. M. Kelly. 2007. Repetitive DNA is associated with centromeric domains in Trypanosoma brucei but not Trypanosoma cruzi. Genome Biol. 8:R37.
298. Obler, D., et al. 2010. Familial dilated cardiomyopathy secondary to dystrophin splice site mutation. J. Card. Fail. 16:194-199.
299. Ogbadoiyi, E. O., D. R. Robinson, and K. Gull. 2003. A high-order transmembrane structural linkage is responsible for mitochondrial genome positioning and segregation by flagellar basal bodies in trypanosomes. Mol. Biol. Cell 14:1769-1779.
300. Oliveira, J. S. 1985. A natural human model of intrinsic heart nervous system denervation: Chagas' cardiopathy. Hum. Pathol. 110:1092-1098.
301. O'Malley, M. A., and Y. Boucher. 2005. Paradigm change in evolutionary microbiology. Stud. Hist. Philos. Biol. Biomed. Sci. 36:183-208.
302. Paba, J., et al. 2004. Proteomic analysis of Trypanosoma cruzi developmental stages using isotope-coded affinity tag reagents. J. Proteome Res. 3:517-524.
303. Paba, J., et al. 2004. Proteomic analysis of the human pathogen Trypanosoma cruzi. Proteomics 4:1052-1059.
304. Padilla, A. M., J. M. Bustamante, and R. L. Tarleton. 2009. CD8+ T cells in Trypanosoma cruzi infection. Curr. Opin. Immunol. 21:385-390.
305. Paiva, C. N., et al. 2007. Unraveling the lethal synergism between Trypanosoma cruzi infection and LPS: a role for increased macrophage reactivity. Eur. J. Immunol. 37:1355-1364.
306. Pan-American Health Organization. 1994. Chagas disease and the nervous system. Scientific publication 547. Pan-American Health Organization, Washington, DC.
307. Paque, R. E., and R. Miller. 1991. Autoanti-idiotypes exhibit mimicry of myocyte antigens in virus-induced myocarditis. J. Virol. 65:16-22.
308. Parada, H., H. A. Carrasco, N. Añez, C. Fuenmayor, and I. Inglessis. 1997. Cardiac involvement is a constant finding in acute Chagas' disease: a clinical, parasitological and histopathological study. Int. J. Cardiol. 60:49-54.
309. Parodi-Talice, A., et al. 2007. Proteomic analysis of metacyclic trypomastigotes undergoing Trypanosoma cruzi metacyclogenesis. J. Mass Spectrom. 42:1422-1432.
310. Passos, S. T., et al. 2010. IL-6 promotes NK cell production of IL-17 during toxoplasmosis. J. Immunol. 184:1776-1783.
311. Paulin, J. 1975. The chondriome of selected trypanosomatids. A threedimensional study based on serial thick sections and high voltage electron microscopy. J. Cell Biol. 66:404-413.
312. Pauschinger, M., et al. 2005. Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response. Eur. J. Heart Fail. 7:444-452.
313. Pellegrini, A., et al. 2007. Spleen B cells from BALB/c are more prone to activation than spleen B cells from C57BL/6 mice during a secondary immune response to cruzipain. Int. Immunol. 19:1395-1402.
314. Pena, S. D., C. R. Machado, and A. M. Macedo. 2009. Trypanosoma cruzi: ancestral genomes and population structure. Mem. Inst. Oswaldo Cruz 104:108-114.
315. Pereira, K. S., et al. 2009. Chagas' disease as a foodborne illness. J. Food. Prot. 72:441-446.
316. Pinheiro, S. W., et al. 2003. Morphometric study of the fibrosis and mast cell count in the circular colon musculature of chronic Chagas patients with and without megacolon. Rev. Soc. Bras. Med. Trop. 36:461-466.
317. Pitta, M. G., et al. 2009. IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani. J. Clin. Invest. 119:2379-2387.
318. Poinar, G., Jr. 2005. Triatoma dominicana sp. n. (Hemíptera: Reduviidae: Triatominae), and Trypannosoma antiquus sp. n. (Stercoraria: Trypanosomatidae), the first fossil evidence of a triatomine-trypanosomatid vector association. Vector Borne Zoonotic Dis. 5:72-81.
319. Prata, A. 1994. Chagas' disease. Infect. Dis. Clin. North Am. 8:61-76.
320. Prata, A. 2001. Clinical and epidemiological aspects of Chagas disease. Lancet Infect. Dis. 1:92-100.
321. Ramos, B., and S. Urdaneta-Morales. 1977. Hematophagous insects as vectors for frog trypanosomes. Rev. Biol. Trop. 25:209-217.
322. Ramos, S. G., L. Matturri, L. Rossi, and M. A. Rossi. 1995. Sudden cardiac death in the intermediate phase of Chagas' disease associated with acute infarction of the right carotid body. Int. J. Cardiol. 52:265-268.
323. Rassi, A., Jr., S. G. Rassi, and A. Rassi. 2001. Sudden death in Chagas' disease. Arq. Bras. Cardiol. 76:75-96.
324. Reed, S. G. 1980. Adoptive transfer of resistance to acute Trypanosoma cruzi infection with T-lymphocyte-enriched spleen cells. Infect. Immun. 28:404-410.
325. Reinhard, K., M. Fink, and J. Skiles. 2003. A case of megacolon in Rio Grande Valley as a possible case of Chagas disease. Mem. Inst. Oswaldo Cruz 98(Suppl. I):165-172.
326. Ribeiro, C. H., et al. 2009. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity. Mol. Immunol. 46:1092-1099.
327. Ribeiro, L. C., A. A. Barbosa, and Z. A. Andrade. 2002. Pathology of intracardiac nerves in experimental Chagas disease. Mem. Inst. Oswaldo Cruz 97:1019-1025.
328. Riou, G., and P. Yot. 1967. Heterogeneity of the kinetoplast DNA molecules of Trypanosoma cruzi. Biochemistry 16:2390-2396.
329. Roberson, E. L., and W. L. Hanson. 1974. Transfer of immunity to T. cruzi. Trans. R. Soc. Trop. Med. Hyg. 68:338.
330. Roberson, E. L., W. L. Chapman, and W. L. Hanson. 1973. The effects of total-body X-irradiation on Trypanosoma cruzi infection (Chagas' disease) in mice and rats. Z. Parasitenkd. 41:83-94.
331. Rocha, A., et al. 1987. ELISA immunoenzymatic assay in the pericardial fluid: a new method for the post-mortem diagnosis of Chagas disease. Rev. Soc. Bras. Med. Trop. 20:213-216.
332. Rodrigues, M. M., B. C. Alencar, and J. R. Vasconcelos. 2009. Acquired immunity against Trypanosoma cruzi infection and vaccine development, p. 94-103. In A. R. L. Teixeira, M. C. Vinaud, and A. M. Castro (ed.), Emerging Chagas disease, 1st ed. Bentham Science Publishers, New York, NY.
333. Rodriguez, A. M., F. Santoro, D. Afchain, H. Bazin, and A. Capron. 1981. Trypanosoma cruzi infection in B-cell-deficient rats. Infect. Immun. 31:524-529.
334. Rose, N. R., A. Herskowitz, and D. A. Neumann. 1993. Autoimmunity in myocarditis: models and mechanisms. Clin. Immunol. Immunopathol. 68: 95-99.
335. Rossi, M. A. 1990. Microvascular changes as a cause of chronic cardiomyopathy in Chagas' disease. Am. Heart J. 120:233-236.
336. Rossi, M. A. 2001. Connective tissue skeleton in the normal left ventricle and in hypertensive left ventricular hypertrophy and chronic chagasic myocarditis. Med. Sci. Monit. 7:820-832.
337. Rudi, K., T. Fossheim, and K. S. Jakobsen. 1999. Restriction cutting independent method for cloning genomic DNA segments outside the boundaries of known sequences. Biotechniques 27:1170-1172, 1176-1177.
338. Rutschow, S., et al. 2010. Left ventricular enlargement in coxsackievirus-B3 induced chronic myocarditis-ongoing inflammation and an imbalance of the matrix degrading system. Eur. J. Pharmacol. 630:145-151.
339. Ryckman, R. E. 1965. Epizootiology of Trypanosoma cruzi in Soutwestern North America. IV. Lizards, laboratory hosts for Trypanosoma cruzi and triatominae. J. Med. Entomol. 2:93.
340. Sadigursky, M., and C. A. Santos-Buch. 1997. A novel receptor mediated ATP transport system regulated by tyrosine and serine/threonine phosphokinases in Trypanosoma cruzi trypomastigotes. Recept. Signal Transduct. 7:29-43.
341. Sadigursky, M., B. F. Von Kreuter, and C. A. Santos-Buch. 1988. Development of chagasic autoimmune myocarditis associated with anti-idiotype reaction. Mem. Inst. Oswaldo Cruz 83:363-366.
342. Sales, P. A., Jr., et al. 2008. The regulatory CD4+CD25+ T cells have a limited role on pathogenesis of infection with Trypanosoma cruzi. Microbes Infect. 10:680-688.
343. Samudio, M., et al. 1999. Local and systemic cytokine expression during experimental chronic Trypanosoma cruzi infection in a Cebus monkey model. Parasite Immunol. 21:451-460.
344. Sanderson, C. J., A. F. Lopez, and M. M. Moreno. 1977. Eosinophils and not lymphoid K cells kill Trypanosoma cruzi epimastigotes. Nature 268:340-341.
345. Sanderson, C. J., and W. de Souza. 1979. A morphological study of the interaction between Trypanosoma cruzi and rat eosinophils, neutrophils and macrophages in vitro. J. Cell Sci. 37:275-286.
346. Santos-Buch, C. A., and A. R. L. Teixeira. 1974. The immunology of experimental Chagas' disease. 3. Rejection of allogeneic heart cells in vitro. J. Exp. Med. 140:38-53.
347. Scharfstein, J., A. C. Monteiro, V. Schmitz, and E. Svensjo. 2008. Angiotensin-converting enzyme limits inflammation elicited by Trypanosoma cruzi cysteine proteases: a peripheral mechanism regulating adaptive immunity via the innate kinin pathway. Biol. Chem. 389:1015-1024.
348. Scharfstein, J., and A. P. Lima. 2008. Roles of naturally occurring protease inhibitors in the modulation of host cell signaling and cellular invasion by Trypanosoma cruzi. Subcell. Biochem. 47:140-154.
349. Scharfstein, J., J. A. Gomes, and R. Correa-Oliveira. 2009. Back to the future in Chagas disease: from animal models to patient cohort studies, progress in immunopathogenesis research. Mem. Inst. Oswaldo Cruz 104(Suppl. 1):187-198.
350. Scharfstein, J., et al. 2000. Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors. J. Exp. Med. 192: 1289-1300.
351. Schenone, H., M. Gaggero, J. Sapúnar, M. C. Contreras, and A. Rojas. 2001. Congenital Chagas disease of second generation in Santiago, Chile. Report of two cases. Rev. Inst. Med. Trop. Sao Paulo 43:231-232.
352. Schiffler, R. J., G. P. Mansur, T. R. Navin, and K. Limpakarn-Janarat. 1984. Indigenous Chagas disease (American trypanosomiasis) in California. JAMA 251:2983-2984.
353. Schlüter, D., N. Kaefer, H. Hof, O. D. Wiestler, and M. Deckert-Schlüter. 1997. Expression pattern and cellular origin of cytokines in the normal and Toxoplasma gondii-infected murine brain. Am. J. Pathol. 150:1021-1035.
354. Schmidtke, M., et al. 2000. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis. J. Med. Virol. 61:518-526.
355. Schmitz, V., E. Svensjö, R. R. Serra, M. M. Teixeira, and J. Scharfstein. 2009. Proteolytic generation of kinins in tissues infected by Trypanosoma cruzi depends on CXC chemokine secretion by macrophages activated via Toll-like 2 receptors. J. Leukoc. Biol. 85:1005-1014.
356. Schmunis, G. A., and Z. E. Yadon. 2010. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop. 115:14-21.
357. Seder, R. A., and W. E. Paul. 1994. Acquisition of lymphokine-producing phenotype by CD4 T cells. Annu. Rev. Immunol. 12:635-673.
358. Seko, Y., N. Takahashi, H. Yagita, K. Okumura, and Y. Yazaki. 1997. Expression of cytokine mRNAs in murine hearts with acute myocarditis caused by coxsackievirus B3. J. Pathol. 183:105-108.
359. Sen, S. K., C. T. Huang, K. Han, and M. A. Batzer. 2007. Endonucleaseindependent insertion provides an alternative pathway for L1 retrotransposition in the human genome. Nucleic Acids Res. 35:3741-3751.
360. Sfriso, P., et al. 2010. Infections and autoimmunity: the multifaceted relationship. J. Leukoc. Biol. 87:385-395.
361. Shapira, S., O. S. Harb, J. Caamano, and C. A. Hunter. 2004. The NFkappaB signaling pathway: immune evasion and immunoregulation during toxoplasmosis. Int. J. Parasitol. 34:393-400.
362. Shapiro, T. A., and P. T. Englund. 1995. The structure and replication of kinetoplast DNA. Annu. Rev. Microbiol. 49:117-143.
363. Sharma, U., and S. Singh. 2009. Immunobiology of leishmaniasis. Indian J. Exp. Biol. 47:412-423.
364. Shrivastav, M., L. P. De Haro, and J. A. Nickoloff. 2008. Regulation of DNA double-strand break repair pathway choice. Cell Res. 18:134-147.
365. Sica, R. E., S. M. Gonzalez Cappa, O. P. Sanz, and G. Mirkin. 1995. Peripheral nervous system involvement in human and experimental chronic American trypanosomiasis. Bull. Soc. Pathol. Exot. 88:156-163.
366. Silva, J. J., et al. 2010. Novel ruthenium complexes as potential drugs for Chagas's disease: enzyme inhibition and in vitro/in vivo trypanocidal activity. Br. J. Pharmacol. 60:260-269.
367. Silveira, C. A., E. Castillo, and C. Castro. 2000. Evaluation of an specific treatment for Trypanosoma cruzi in children, in the evolution of the intermediate phase. Rev. Soc. Bras. Med. Trop. 33:191-196.
368. Simões-Barbosa, A., et al. 2006. Hitchhiking Trypanosoma cruzi minicircle DNA affects gene expression in human host cells via LINE-1 retrotransposon. Mem. Inst. Oswaldo Cruz 101:833-843.
369. Simpson, A. G. B., J. R. Stevens, and J. Lukes. 2006. The evolution and diversity of kinetoplastid flagellates. Trends Parasitol. 22:168-174.
370. Simpson, A. G., T. A. Perley, and E. Lara. 2008. Lateral transfer of the gene for a widely used marker, alpha-tubulin, indicated by a multi-protein study of the phylogenetic position of Andalucia (Excavata). Mol. Phylogenet. Evol. 47:366-377.
371. Soares, C. M., et al. 1989. Alpha-and beta-tubulin mRNAs of Trypanosoma cruzi originate from a single multicistronic transcript. FEBS Lett. 250:497-502.
372. Sodré, C. L., et al. 2009. Proteomic map of Trypanosoma cruzi CL Brener: the reference strain of the genome project. Arch. Microbiol. 191:177-184.
373. Solari, A. J. 1995. Mitosis and genome partition in trypanosomes. Biocell 19:65-84.
374. Song, M., and S. Boissinot. 2007. Selection against LINE-1 retrotransposons results principally from their ability to mediate ectopic recombination. Gene 390:206-213.
375. Sosa Estani, S., et al. 1998. Efficacy of chemotherapy with benznidazole in children in the intermediate phase of Chagas' disease. Am. J. Trop. Med. Hyg. 59:526-529.
376. Souza, P. E., et al. 2007. Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with intermediate and cardiac Chagas' disease. Infect. Immun. 75:1886-1894.
377. Spivak, J. L. 2004. The chronic myeloproliferative disorders: clonality and clinical heterogeneity. Semin. Hematol. 41(2 Suppl. 3):1-5.
378. Srikanta, D., et al. 2009. An alternative pathway for Alu retrotransposition suggests a role in DNA double-strand break repair. Genomics 93:205-212.
379. Srikanta, D., S. K. Sen, E. M. Conlin, and M. A. Batzer. 2009. Internal priming: an opportunistic pathway for L1 and Alu retrotransposition in hominins. Gene 448:233-241.
380. Steinert, G., H. Firket, and M. Steinert. 1958. Synthese d'acide désoxyribonucléique dans le corps parabasal de Trypanosoma mega. Exp. Cell Res. 15:632-635.
381. Stevens, J. R., and W. C. Gibson. 1999. The evolution of pathogenic trypanosomes. Cad. Saude Publica 15:673-684.
382. Stevens, J. R., H. A. Noyes, C. J. Schofield, and W. Gibson. 2001. The molecular evolution of trypanosomatidae. Adv. Parasitol. 48:1-56.
383. Stimpert, K. K., and S. P. Montgomery. 2010. Physician awareness of Chagas disease, USA. Emerg. Infect. Dis. 16:871-872.
384. Sturm, N. R. 2009. Trypanosoma cruzi mitochondrial DNA and the parasite lifecycle, p. 63-69. In A. R. L. Teixeira, M. C. Vinaud, and A. M. Castro (ed.), Emerging Chagas disease, 1st ed. Bentham Science Publishers, New York, NY.
385. Sturm, N. R., W. Degrave, C. Morel, and L. Simpson. 1989. Sensitive detection and schizodeme classification of Trypanosoma cruzi cells by amplification of kinetoplast minicircle DNA sequences: use in diagnosis of Chagas' disease. Mol. Biochem. Parasitol. 33:205-214.
386. Suzuki, J., et al. 2009. Genetic evidence that the non-homologous endjoining repair pathway is involved in LINE retrotransposition. PLoS Genet. 5:e1000461.
387. Suzuki, Y., et al. 2000. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J. Immunol. 164:5375-5382.
388. Tafuri, L., T. A. Maria, and E. R. Lopes. 1970. Pathogenesis of lesions of the autonomic nervous system of the mouse in experimental acute Chagas' disease. Light and electron microscope studies. Am. J. Trop. Med. Hyg. 19:405-417.
389. Tafuri, W. L. 1971. Light and electron microscope studies of the autonomic nervous system in experimental and human American trypanosomiasis. Virchows Arch. A Pathol. Anat. Histol. 354:136-349.
390. Tafuri, W. L., T. A. Maria, E. R. Lopes, and E. Chapadeiro. 1973. Electron microscopy of the myocardium in human trypanosomiasis cruzi. Rev. Inst. Med. Trop. Sao Paulo 15:347-370.
391. Takehara, H. A., A. Perini, M. H. da Silva, and I. Mota. 1981. Trypanosoma cruzi: role of different antibody classes in protection against infection in the mouse. Exp. Parasitol. 52:137-146.
392. Takle, G. B., A. Young, D. Snary, L. Hudson, and S. C. Nicholls. 1989. Cloning and expression of a trypomastigote-specific 85-kilodalton surface antigen gene from Trypanosoma cruzi. Mol. Biochem. Parasitol. 37:57-64.
393. Tanowitz, H. B., et al. 2009. Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog. Cardiovasc. Dis. 51:524-539.
394. Tanowitz, H. B., et al. 1992. Chagas' disease. Clin. Microbiol. Rev. 5:400-419.
395. Tarleton, R. L. 2001. Parasite persistence in the aetiology of Chagas disease. Int. J. Parasitol. 31:550-554.
396. Tarleton, R. L. 2003. Chagas disease: a role for autoimmunity? Trends Parasitol. 19:447-451.
397. Tarleton, R. L., and L. Zhang. 1999. Chagas disease etiology: autoimmunity or parasite persistence? Parasitol. Today 15:94-99.
398. Tarleton, R. L., L. Zhang, and M. O. Downs. 1997. Autoimmune rejection of neonatal heart transplants in experimental Chagas disease is a parasitespecific response to infected host tissue. Proc. Natl. Acad. Sci. U. S. A. 94:3932-3937.
399. Teixeira, A. R. 1986. Chagas' disease in inbred III/J rabbits. Am. J. Pathol. 124:363-365.
400. Teixeira, A. R. L., C. M. Ripoll, and C. A. Santos-Buch. 1996. Autoimmunity in Chagas disease, p. 233-255. In H. Friedman, N. R. Rose, and M. Bendinelli (ed.), Microorganisms and autoimmune diseases. Plenum Press, New York, NY.
401. Teixeira, A. R. L. 1987. Immunoprophylaxis against Chagas disease, p. 243-280. In L. H. Miller, J. A Pino, and J. J. McKelvey, Jr. (ed.), Immunity to blood parasites of animals and man. Plenum Press, New York, NY.
402. Teixeira, A. R. L., and C. A. Santos-Buch. 1974. The immunology of experimental Chagas' disease. I. Preparation of Trypanosoma cruzi antigens and humoral antibody response to these antigens. J. Immunol. 113:859-869.
403. Teixeira, A. R. L., and C. A. Santos-Buch. 1975. The immunology of experimental Chagas' disease. II. Delayed hypersensitivity to Trypanosoma cruzi antigens. Immunology 28:401-410.
404. Teixeira, A. R. L., et al. 2011. Trypanosoma cruzi in the chicken model: Chagas-like heart disease in the absence of parasitism. PLoS Negl. Trop. Dis. 5:e1000.
405. Teixeira, A. R. L., E. Jabur, J. C. Córdoba, I. C. S. Mayor, and E. Solorzano. 1983. Alterac ̧a ̃o da resposta imune mediada por células durante o tratamento com benzonidazol. Rev. Soc. Bras. Med. Trop. 16:11-22.
406. Teixeira, A. R. L., F. Pimentel, and C. Cordeiro. 2009. The pathology of Chagas disease, p. 110-121. In A. R. L. Teixeira, M. C. Vinaud, and A. M. Castro (ed.), Emerging Chagas disease, 1st ed. Bentham Science Publishers, New York, NY.
407. Teixeira, A. R. L., F. Roters, and K. E. Mott. 1970. Acute Chagas disease. Gaz. Med. Bahia 3:176-186.
408. Teixeira, A. R. L., M. C. Vinaud, and A. M. Castro. 2009. Chagas disease: a global health problem, p. 18-23. In A. R. L. Teixeira, M. C. Vinaud, and A. M. Castro (ed.), Emerging Chagas disease, 1st ed. Bentham Science Publishers, New York, NY.
409. Teixeira, A. R. L., N. Nitz, M. C. Guimaro, C. Gomes, and C. A. Santos-Buch. 2006. Chagas disease. Postgrad. Med. J. 82:788-798.
410. Teixeira, A. R. L., R. Nascimento, and N. R. Sturm. 2006. Evolution and pathology in Chagas disease. Mem. Inst. Oswaldo Cruz 101:463-491.
411. Teixeira, A. R., and M. G. Teixeira. 1995. Delayed hypersensitivity to Trypanosoma cruzi antigen. III. Sensitivity of the skin test with T12E antigen in the diagnosis of Chagas disease in hospitalized patients. Rev. Soc. Bras. Med. Trop. 28:267-271.
412. Teixeira, A. R., et al. 2009. Environment, interactions between Trypanosoma cruzi and its host, and health. Cad. Saude Publica 25(Suppl. 1):S32-S44.
413. Teixeira, A. R., E. Cunha Neto, L. V. Rizzo, and R. Silva. 1990. Trypanocidal nitroarene treatment of experimental Trypanosoma cruzi infection does not prevent progression of chronic-phase heart lesions in rabbits. J. Infect. Dis. 162:1420.
414. Teixeira, A. R., Z. Lacava, J. M. Santana, and H. Luna. 1991. Insertion of Trypanosoma cruzi DNA in the genome of mammal host cell through infection. Rev. Soc. Bras. Med. Trop. 24:55-58.
415. Teixeira, A. R., et al. 1994. Possible integration of Trypanosoma cruzi kDNA minicircles into the host cell genome by infection. Mutat. Res. 305:197-209.
416. Teixeira, A. R., G. Teixeira, V. Macedo, and A. Prata. 1978. Acquired cell-mediated immunodepression in acute Chagas' disease. J. Clin. Invest. 62:1132-1141.
417. Teixeira, A. R., J. C. Cordoba, I. Souto Maior, and E. Solorzano. 1990. Chagas' disease: lymphoma growth in rabbits treated with benznidazole. Am. J. Trop. Med. Hyg. 43:146-158.
418. Teixeira, A. R., L. F. Junqueira, E. Solorzano, and M. Zappala. 1983. Experimental Chagas' disease in isogenic III/J rabbits. I. Physiopathology of arrhythmia and sudden death in Chagas' disease patients. Rev. Assoc. Med. Bras. 29:77-83.
419. Teixeira, A. R., M. L. Teixeira, and C. A. Santos-Buch. 1975. The immunology of experimental Chagas' disease. IV. Production of lesions in rabbits similar to those of chronic Chagas' disease in man. Am. J. Pathol. 80:163-180.
420. Teixeira, A. R., et al. 2001. Emerging Chagas disease: trophic network and cycle of transmission of Trypanosoma cruzi from palm trees in the Amazon. Emerg. Infect. Dis. 7:100-112.
421. Teixeira, A. R., R. Silva, E. Cunha Neto, J. M. Santana, and L. V. Rizzo. 1990. Malignant, non-Hodgkin's lymphomas in Trypanosoma cruzi-infected rabbits treated with nitroarenes. J. Comp. Pathol. 103:37-48.
422. Tiede, A., I. Bastisch, J. Schubert, P. Orlean, and R. E. Schmidt. 1999. Biosynthesis of glycosylphosphatidylinositols in mammals and unicellular microbes. Biol. Chem. 380:503-523.
423. Todorov, A. G., et al. 2003. Trypanosoma cruzi induces edematogenic responses in mice and invades cardiomyocytes and endothelial cells in vitro by activating distinct kinin receptor (B1/B2) subtypes. FASEB J. 17:73-75.
424. Tomlinson, S., F. Vandekerckhove, U. Frevert, and V. Nussenzweig. 1995. The induction of Trypanosoma cruzi trypomastigote to amastigote transformation by low pH. Parasitology 110:547-554.
425. Torres, C. M. 1930. Patogenia de la miocarditis cronica em la enfermedad de Chagas. Soc. Argent. Patol. Reg. Norte Quinta Reun. 2:902.
426. Torres, C. M. 1960. Myocytolysis and fibrosis of the myocardium in Chagas' disease. Mem. Inst. Oswaldo Cruz 58:161-182.
427. Torres, S. H., et al. 2004. Capillary damage in skeletal muscle in advanced Chagas disease patients. Parasitol. Res. 93:364-368.
428. Trischmann, T., H. Tanowitz, M. Wittner, and B. Bloom. 1978. Trypanosoma cruzi: role of the immune response in the natural resistance of inbred strains of mice. Exp. Parasitol. 45:160-168.
429. Trischmann, T. M. 1986. Trypanosoma cruzi: early parasite proliferation and host resistance in inbred strains of mice. Exp. Parasitol. 62:194-201.
430. Tzelepis, F., et al. 2008. Infection with Trypanosoma cruzi restricts the repertoire of parasite-specific CD8+ T cells leading to immunodominance. J. Immunol. 180:1737-1748.
431. Urdaneta-Morales, S., and I. McLure. 1981. Experimental infections in Venezuelan lizards by Trypanosoma cruzi. Acta Trop. 38:99-105.
432. Vago, A. R., et al. 2000. Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic Chagas disease: differential distribution of genetic types into diverse organs. Am. J. Pathol. 156:1805-1809.
433. Vago, A. R., et al. 1996. Kinetoplast DNA signatures of Trypanosoma cruzi strains obtained directly from infected tissues. Am. J. Pathol. 149:2153-2159.
434. Vago, A. R., D. M. Silva, S. J. Adad, R. Correa-Oliveira, and D. d'Avila Reis. 2003. Chronic Chagas disease: presence of parasite DNA in the oesophagus of patients without megaoesophagus. Trans. R. Soc. Trop. Med. Hyg. 97: 308-309.
435. Vaidian, A. K., L. M. Weiss, and H. B. Tanowitz. 2004. Chagas' disease and AIDS. Kinetoplastid Biol. Dis. 3:2.
436. Van Baarlen, P., A. Van Belkum, R. C. Summerbell, P. W. Crous, and B. P. Thomma. 2007. Molecular mechanisms of pathogenicity: how do pathogenic microorganisms develop cross-kingdom host jumps? FEMS Microbiol. Rev. 31:239-277.
437. van der Poll, T., E. E. Zijlstra, and M. Mevissen. 1995. Interleukin 6 during active visceral leishmaniasis and after treatment. Clin. Immunol. Immunopathol. 77:111-114.
438. Vianna, G. O. 1911. On pathologic anatomy in Chagas disease. Mem. Inst. Oswaldo Cruz 3:276-294.
439. Vickerman, K. 1969. On the surface coat and flagellar adhesion in trypanosomes. J. Cell Sci. 5:163-194.
440. Vickerman, K. 1976. The diversity of the kinetoplastid flagellates, p. 1-34. In W. H. R. Lumsden and D. A. Evans (ed.), Biology of the Kinetoplastida. Academic Press, London, United Kingdom.
441. Villalta, F., et al. 2009. Perspectives on the Trypanosoma cruzi-host cell receptor interactions. Parasitol. Res. 104:1251-1260.
442. Villalta, F., Y. Zhang, K. E. Bibb, J. M. Burns, and M. F. Lima. 1998. Signal transduction in human macrophages by gp83 ligand of Trypanosoma cruzi: trypomastigote gp83 ligand up-regulates trypanosome entry through the MAP kinase pathway. Biochem. Biophys. Res. Commun. 249:247-252.
443. von der Heyden, S., E. E. Chao, K. Vickerman, and T. Cavalier-Smith. 2004. Ribosomal RNA phylogeny of bodonid and diplonemid flagellates and the evolution of euglenozoa. J. Eukaryot. Microbiol. 51:402-416.
444. Von Kreuter, B. F., B. L. Walton, and C. A. Santos-Buch. 1995. Attenuation of parasite cAMP levels in T. cruzi-host cell membrane interactions in vitro. J. Eukaryot. Microbiol. 42:20-26.
445. Vossenkämper, A., et al. 2004. Both IL-12 and IL-18 contribute to small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii, but IL-12 is dominant over IL-18 in parasite control. Eur. J. Immunol. 34:3197-3207.
446. Votýpka, J., et al. 2010. Probing into the diversity of trypanosomatid flagellates parasitizing insect hosts in South-West China reveal both endemism and global dispersal. Mol. Phylogenet. Evol. 54:243-253.
447. Watanabe, M. A., and G. Schmidt. 2004. Heart rate turbulence: a 5-year review. Heart Rhythm 1:732-738.
448. Weatherly, D. B., C. Boehlke, and R. L. Tarleton. 2009. Chromosome level assembly of the hybrid Trypanosoma cruzi genome. BMC Genomics 10:255.
449. Weaver, C. T., R. D. Hatton, P. R. Mangan, and L. E. Harrington. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25:821-852.
450. Weremeichik, H., A. Moraska, M. Herzum, A. Weller, and S. A. Huber. 1991. Naturally occurring anti-idiotypic antibodies-mechanisms for autoimmunity and immunoregulation? Eur. Heart J. 12(Suppl. D):154-157.
451. Reference deleted.
452. Williams, J. T., E. J. Dick, J. L. VandeBerg, and G. B. Hubbard. 2009. Natural Chagas disease in four baboons. J. Med. Primatol. 38:107-113.
453. Wilson, M. S., et al. 2010. Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections. J. Immunol. 184:4378-4390.
454. Woody, N. C., and H. B. Woody. 1961. American Trypanosomiasis. I. Clinical and epidemiologic background of Chagas disease in the United States. J. Pediatr. 58:568.
455. World Health Organization. 2002. Control of Chagas' disease: second report of a WHO Expert Committee. World Health Organ. Tech. Rep. Ser. 905:1-109.
456. Xavier, S. C., et al. 2007. Mapping of the distribution of Trypanosoma cruzi infection among small wild mammals in a conservation unit and its surroundings (Northeast-Brazil). Parasitol. Int. 56:119-128.
457. Xing, Z., C. J. Cardona, J. Anunciacion, S. Adams, and N. Dao. 2010. Roles of the ERK MAPK in the regulation of proinflammatory and apoptotic responses in chicken macrophages infected with H9N2 avian influenza virus. J. Gen. Virol. 91:343-351.
458. Yeo, M., et al. 2005. Origins of Chagas disease: didelphis species are natural hosts of Trypanosoma cruzi I and armadillos hosts of Trypanosoma cruzi II, including hybrids. Int. J. Parasitol. 35:225-233.
459. York, I. A., A. L. Goldberg, X. Y. Mo, and K. L. Rock. 1999. Proteolysis and class I major histocompatibility complex antigen presentation. Immunol. Rev. 172:49-66.
460. Yun, M. H., and K. Hiom. 2009. CtIP-BRCA1 modulates the choice of DNA double-strand-break repair pathway throughout the cell cycle. Nature 459:460-463.
461. Zacks, M. A., and N. Garg. 2006. Recent developments in the molecular, biochemical and functional characterization of GPI8 and the GPI-anchoring mechanism. Mol. Membr. Biol. 23:209-225.
462. Zhang, L., and R. L. Tarleton. 1996. Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production. Eur. J. Immunol. 26:102-109.
463. Zhang, L., and R. L. Tarleton. 1999. Parasite persistence correlates with disease severity and localization in chronic Chagas' disease. J. Infect. Dis. 180:480-486.
464. Zhang, M., et al. 2010. The Plasmodium eukaryotic initiation factor-2alpha kinase IK2 controls the latency of sporozoites in the mosquito salivary glands. J. Exp. Med. 207:1465-1474.
465. Zhou, L., M. M. Chong, and D. R. Littman. 2009. Plasticity of CD4+ T cell lineage differentiation. Immunity 30:646-655.
466. Zhu, J., and W. E. Paul. 2010. Heterogeneity and plasticity of T helper cells. Cell Res. 20:4-12.
467. Ziegler, A., G. Dohr, and B. Uchanska-Ziegler. 2002. Possible roles for products of polymorphic MHC and linked olfactory receptor genes during selection processes in reproduction. Am. J. Reprod. Immunol. 48:34-42.
468. Zíková, A., et al. 2008. Trypanosoma brucei mitochondrial ribosomes: affinity purification and component identification by mass spectrometry. Mol. Cell. Proteomics 7:1286-1296.
469. Zingler, N., et al. 2007. Analysis of 5 junctions of human LINE-1 and Alu retrotransposons suggests an alternative model for 5-end attachment requiring microhomology-mediated end-joining. Genome Res. 15:780-789.